InMed Pharmaceuticals INM
NASDAQ INM
$12.20 -3.80 (-23.75%)
At close: Nov 10, 2026 · 4:00 PM EST

InMed Pharmaceuticals (INM) Income from Discontinued Operations (2025 - 2026)

Updated

InMed Pharmaceuticals (INM) recorded Income from Discontinued Operations of -$996,330 in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $46,305 a year earlier.

Analysis

InMed Pharmaceuticals (INM) Income from Discontinued Operations (2025 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), InMed Pharmaceuticals reported Income from Discontinued Operations of -$1.19 million.

  • Across earlier fiscal years, Income from Discontinued Operations came in at $528,175 in FY2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Linde 239.54 Bn 223.24 Bn 4.44 Bn -
2 Corning 96.61 Bn 88.91 Bn 1.81 Bn -
3 Sherwin Williams 85.84 Bn 84.86 Bn 3.28 Bn -
4 Air Products & Chemicals 69.53 Bn 72.40 Bn - -
5 LyondellBasell Industries 39.13 Bn 27.31 Bn 1.50 Bn -18.00 Mn
6 Nutrien 34.78 Bn 31.35 Bn 1.86 Bn -
7 Ppg Industries 27.48 Bn 20.55 Bn 1.76 Bn -22.00 Mn
8 Qnity Electronics 25.83 Bn 22.27 Bn 743.00 Mn -
9 Ati 24.82 Bn 22.90 Bn 380.20 Mn -
10 InMed Pharmaceuticals 8.79 Mn 7.69 Mn - -335,766.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -335,766.00
Jun 30, 2026 -996,330.00
Mar 31, 2026 -174,585.00
Sep 30, 2025 103,449.00
Jun 30, 2025 46,305.00
Mar 31, 2025 -53,861.00
API Access

InMed Pharmaceuticals Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=INM&period=max&api_key=YOUR_API_KEY